GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
8E57 | P13806 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution | |
8E56 | P07293 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution | |
8E56 | P19518 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution | |
8E56 | P13806 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution | |
8E4Z | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 8 | |
8E4K | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 7 | |
8E4I | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 6 | |
8E4C | P01872 | IgM BCR fab truncated form | |
8E4C | P11911 | IgM BCR fab truncated form | |
8E4C | P21578 | IgM BCR fab truncated form | |
8E4C | P15530 | IgM BCR fab truncated form | |
8E3P | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 5 | |
8E3J | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 4 | |
8E1W | A0A0S2GKZ1 | Neutron crystal structure of Panus similis AA9A at room temperature | |
8E1P | 8E1P | Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs | |
8E1P | Q2N0S6 | Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs | |
8E1G | P0DTC2 | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
8E1G | 8E1G | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
8E15 | Q8B9P0 | A computationally stabilized hMPV F protein | |
8E15 | Q76VI8 | A computationally stabilized hMPV F protein | |
8E0W | Q3U128 | Crystal structure of mouse APCDD1 in P1 space group | |
8E0V | P0AB91 | DAHP (3-deoxy-D-arabinoheptulosonate-7-phosphate) Synthase complexed with Mn(II), PEP, and Pi in unbound:(bound)2:other Conformations | |
8E0S | P0AB91 | DAHP (3-deoxy-D-arabinoheptulosonate-7-phosphate) Synthase complexed with DAHP Oxime in unbound:(bound)2:unbound conformations | |
8E0R | Q3U128 | Crystal structure of mouse APCDD1 in P21 space group | |
8E0P | C3SHQ8 | Crystal structure of mouse APCDD1 in fusion with engineered MBP | |
8E0P | Q3U128 | Crystal structure of mouse APCDD1 in fusion with engineered MBP | |
8E08 | Q9Y251 | Crystal structure of HPSE P6 in complex with tetraose pentosan inhibitor | |
8E07 | Q9Y251 | Crystal structure of HPSE P6 in complex with triose pentosan inhibitor | |
8DZI | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8DZI | 8DZI | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8DZH | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8DZH | 8DZH | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8DZD | A0QY10 | Structure of MS3494 from Mycobacterium smegmatis bound to sucrose | |
8DYA | A0A8B6RDW3 | Structure of the SARS-CoV-2 spike glycoprotein S2 subunit | |
8DY6 | 8DY6 | Vaccine elicited Antibody MU89+S27Y bound to CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 Env trimer | |
8DXU | 8DXU | Fab arms of antibodies GAR03 and 10G4 bound to the receptor binding domain of SARS-CoV-2 in a 1:1:1 complex. | |
8DXU | P0DTC2 | Fab arms of antibodies GAR03 and 10G4 bound to the receptor binding domain of SARS-CoV-2 in a 1:1:1 complex. | |
8DXT | 8DXT | Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2. | |
8DXT | P0DTC2 | Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2. | |
8DXS | P0DTC2 | Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
8DXS | 8DXS | Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
8DWY | Q5XXP3 | Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit) | |
8DWY | 8DWY | Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit) | |
8DWX | Q5XXP3 | Chikungunya VLP in complex with neutralizing Fab 506.C01 (asymmetric unit) | |
8DWX | 8DWX | Chikungunya VLP in complex with neutralizing Fab 506.C01 (asymmetric unit) | |
8DWW | Q5XXP3 | Chikungunya VLP in complex with neutralizing Fab 506.A08 (asymmetric unit) | |
8DWW | 8DWW | Chikungunya VLP in complex with neutralizing Fab 506.A08 (asymmetric unit) | |
8DWD | P83847 | Adenine glycosylase MutY variant E43S in complex with DNA containing d(8-oxo-G) paired with an AP site generated by the enzyme acting on purine | |
8DWB | Q8AZ87 | Neuraminidase from influenza virus A/Moscow/10/1999(H3N2) in complex with sialic acid | |
8DWA | P0DTC2 | Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024